Rivastigmine is safe and effective for at least 22 months in patients with subcortical vascular dementia
•
Torre P
•
Antonello RM
altro
Cazzato G.
2003
Abstract
Rivastigmine as buthyrrylcholinesterase effective in vasculr dementia
Archivio
Diritti
metadata only access
Soggetti